Cargando…

Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, mainly due to difficulty in early detection of the disease by current imaging modalities. In this review, we discuss the more specific diagnostic imaging modality that evaluates the presence of specific tumour tracers vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poels, Thomas T., Vuijk, Floris A., de Geus-Oei, Lioe-Fee, Vahrmeijer, Alexander L., Oprea-Lager, Daniela E., Swijnenburg, Rutger-Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699493/ https://www.ncbi.nlm.nih.gov/pubmed/34944781 http://dx.doi.org/10.3390/cancers13246164

Ejemplares similares

Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy
por: van Dam, Martijn A., et al.
Publicado: (2021)

Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
por: Oprea-Lager, Daniela E., et al.
Publicado: (2021)

Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography
por: González-Gómez, Ruth, et al.
Publicado: (2021)

Fludeoxyglucose positron emission tomography-computed tomography scan showing polyarthritis in a patient with an atypical presentation of Henoch-Schönlein vasculitis without clinical signs of arthritis: a case report
por: Mooij, Christiaan F., et al.
Publicado: (2016)

The Value of (18)F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
por: Bijlstra, Okker D., et al.
Publicado: (2022)

Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013)

Prostate-Specific Membrane Antigen Targeted Pet/CT Imaging in Patients with Colon, Gastric and Pancreatic Cancer
por: Vuijk, Floris A., et al.
Publicado: (2022)

Editorial on Special Issue “Quantitative PET and SPECT”
por: van Velden, Floris H. P., et al.
Publicado: (2022)

(18)F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) – A prospective externally validated study
por: Carvalho, Sara, et al.
Publicado: (2018)

Optimal respiratory-gated [(18)F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma
por: Smeets, Esther M. M., et al.
Publicado: (2019)

Quantitative Assessment of Radionuclide Uptake and Positron Emission Tomography-computed Tomography Image Contrast
por: Francis, Hasford, et al.
Publicado: (2016)

Predictive and prognostic value of FDG-PET
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2008)

Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma
por: Tummers, Willemieke S., et al.
Publicado: (2017)

Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment
por: Vuijk, F. A., et al.
Publicado: (2020)

Usefulness of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
por: Yokose, Takahiro, et al.
Publicado: (2020)

Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice
por: van de Luijtgaarden, A.C.M., et al.
Publicado: (2008)

Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer
por: Meijer, T. Susanna, et al.
Publicado: (2022)

When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer
por: Caldarella, Carmelo, et al.
Publicado: (2013)

Multiparameter diagnostic model based on (18)F-FDG positron emission tomography and serological examination for differentiating focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: Wang, Guanyun, et al.
Publicado: (2023)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

Methodological considerations in quantification of oncological FDG PET studies
por: Vriens, Dennis, et al.
Publicado: (2009)

Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
por: Meijer, T. Susanna, et al.
Publicado: (2019)

Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors
por: Grey, Neil, et al.
Publicado: (2022)

Defining the Optimal Method for Measuring Metabolic Tumor Volume on Preoperative (18)F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography as a Prognostic Predictor in Patients With Pancreatic Ductal Adenocarcinoma
por: Tatewaki, Yasuko, et al.
Publicado: (2021)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Dose escalation biodistribution, positron emission tomography/computed tomography imaging and dosimetry of a highly specific radionuclide-labeled non-blocking nanobody
por: Yang, Yanling, et al.
Publicado: (2021)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [(18)F]-FDOPA PET/CT study
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Positron emission tomography: An overview
por: Shukla, A. K., et al.
Publicado: (2006)

Scintillators for positron emission tomography
por: Moses, W W, et al.
Publicado: (1995)

Detectors in positron emission tomography
por: Zatcepin, Artem, et al.
Publicado: (2022)

Radiochemistry for positron emission tomography
por: Rong, Jian, et al.
Publicado: (2023)

Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study
por: Meijer, T. Susanna, et al.
Publicado: (2020)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

Imaging pancreatic islet cells by positron emission tomography
por: Li, Junfeng, et al.
Publicado: (2016)

The Impact of Metabolic (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters on the Prognosis of Resectable Pancreatic Adenocarcinoma
por: Ekmekçioğlu, Özgül, et al.
Publicado: (2023)

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
por: Carretta, Angelo, et al.
Publicado: (2020)

Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
por: Oldan, Jorge Daniel, et al.
Publicado: (2018)

Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer
por: Bodar, Yves J.L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pcm017682q73a47kja7p15sltn